NCT05402033Recruiting
Cancer Clinical Trials Financial Reimbursement Program
Enhancement of Access to and Diversity in Cancer Clinical Trials Through a Financial Reimbursement and Outreach Program
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 24 May 2022
- Start date
- 12 Jul 2022
- Primary completion date
- 1 Jun 2029
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Childhood cancers
- NCT number
- NCT05402033
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 12 Jul 2022 to the primary completion date, 1 Jun 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not enrolled in a clinical trial
- Does not speak English or Spanish
Who the study is looking for
- Be enrolled in a therapeutic cancer clinical trial
- Speak English or Spanish
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.